Stent Graft with Fenestration
Summary
The European Patent Office published patent application EP3881800A1 for a stent graft with fenestration, filed by RIBS, Inc. (inventor: OHKI Takao). The patent application was published March 25, 2026, designating all EU member states. This represents a routine patent publication with no immediate compliance implications for regulated entities.
What changed
The European Patent Office published patent application EP3881800A1 titled 'Stent Graft Having Fenestration Part' filed by RIBS, Inc. with inventor OHKI Takao. The application relates to medical devices in the prosthetics field (IPC classification A61F 2/07) and designates all EU member states plus other EPC contracting states.
This document is a standard patent publication notice and does not impose any compliance obligations, reporting requirements, or deadlines on industry participants. Companies developing or manufacturing fenestrated stent graft technology should monitor the prosecution of this application if it may affect their freedom to operate. No immediate action is required by compliance teams.
Source document (simplified)
STENT GRAFT HAVING FENESTRATION PART
Publication EP3881800A1 Kind: A1 Mar 25, 2026
Applicants
RIBS, Inc.
Inventors
OHKI Takao
IPC Classifications
A61F 2/07 20130101AFI20220602BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.